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ABSTRACT 
The practice of retail pharmacy has become burdened with service limitations directly 
or indirectly resulting from influences across the landscape. Influences ranging from 
legislative bodies to financing bodies have created pressure on retail pharmacies 
resulting in diminishing numbers of these health establishments. Legislative 
amendments relating to the ownership of pharmacies, pricing and pharmacy 
personnel training have had a profound effect on the pharmacy landscape as it 
presents to date. The dual role, (medicinal procurer and pharmaceutical caregiver), 
required of retail pharmacists, poses ethical and practical implications. These 
implications may directly affect the sustainability of retail pharmacy practice.   
The aim of this study was to establish the ways in which the pharmacy model is 
changing and how that change has been perceived by retail pharmacists in 
Johannesburg, Gauteng. 
The research design was qualitative, exploratory, descriptive and contextual in nature. 
The method utilised for gathering data was individual interviews with pharmacists 
practising as independent retail pharmacists. At least six (6) independent pharmacists 
who met the inclusion criteria were approached to participate in the research. 
Interviews continued until data saturation had been achieved. Data analysis of the 
transcribed interviews was performed to identify themes and sub-themes. 
Key words: Retail pharmacist, independent pharmacist, profitability, sustainability.  
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CHAPTER 1 
INTRODUCTION 
1.1 BACKGROUND TO THE STUDY 
A business is defined as an organisation in which the activity of making, buying, selling 
or supplying goods and services for money takes place (Ashby, 2000:148). The sole 
purpose of any business is to trade (goods or services) with the intention of generating 
an income. 
Pharmacy is the science and technique of preparing and dispensing drugs. It serves 
to link the health profession with the chemical sciences. The scope of pharmacies 
combines the more traditional roles of compounding and dispensing medication with 
the more modern roles relating to health care, including primary healthcare and the 
provision of information pertaining to drugs (Moulin, 2013:989). 
An establishment where pharmacy is practiced is referred to as a pharmacy (United 
States) or a chemist (Great Britain and Canada). Pharmacy is a word derived from the 
root word ‘pharma’ (Greek roots), which often operated from a retail shop. Such a 
place was known as an ‘apothecary.’ The Greek word “pharmakeia” was derived from 
pharmakon, meaning drug or medicine (Flannery, 2012:113). 
Pharmacies sell medicine, as well as other miscellaneous items such as gifts, 
toiletries, sweets, chocolates and so forth. Historically retail pharmacies have also 
been involved in the sale of generic or brand medications and sometimes medical 
devices as the main source of income (Malangu, 2014:226). 
According to the Pharmacy Act 53 of 1974 as amended, (hereafter referred to as the 
Pharmacy Act), retail pharmacies in South Africa are licensed entities in which 
compounding, counselling and dispensing of medicinal substances occurs under the 
supervision of a registered pharmacist. Registration of qualified individuals is with the 
South African Pharmacy Council (SAPC), a statutory body that regulates the practice 
of pharmacy in South Africa. This constitutes the practice element of an entity. A 
licence to practice as a retail pharmacy is issued to a registered company or sole 
proprietor by the Department of Health (DoH). Consequent to the trade of services 
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and/or of a commodity for a fee, a retail pharmacy is thus recognised as a business 
and is also known as a community pharmacy. Although drug procurement and 
dispensing feature as significant elements of the service offerings, pharmacists have 
become key in professional service rendition. Retail pharmacy is envisaged as the 
base point of professional primary healthcare services (Wessels & Luiz, 2003:11). 
Retail pharmacies are positioned as the last and pivotal step in medicine procurement. 
The supply chain begins with the product manufacturer and continues to the 
wholesaler or distributor and finally the retail outlet (pharmacy). Inversely, a pharmacy 
is one of the public’s first points of contact with healthcare services, as acknowledged 
by the National Health Plan Strategy (Department of Health, 2009). Pharmacies and 
pharmacists are therefore at the forefront of healthcare service provision. Other 
important role players in the supply chain are prescribing doctors and healthcare 
funders (also referred to as medical aids). Pharmacists’ contribution to primary 
healthcare is significant, with numerous ailments resolved by over-the-counter (OTC) 
recommendations (Gilbert, 1998:273). 
The South African Pharmacy Council reports that there are currently 3303 community 
pharmacies nationally. Fig 1.1 illustrates the distribution of these pharmacies across 
the nine provinces of South Africa. 
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Key: EC – Eastern Cape; FS – Free State; KZN – KwaZulu Natal; LP – Limpopo; MP 
– Mpumalanga; NW – North West; NC – Northern Cape; WC – Western Cape; 
GP – Gauteng Province.  
Source: SAPC annual report, 2014 
Figure 1.1: Percentage of community pharmacies per province (n = 3,303)  
1.2 MOTIVATION OF THE STUDY 
The South African pharmaceutical market (ethical drugs excluding consumer health 
and animal health) grew by 11.7% in 2013 to reach a value of US $2 billion (Marketline, 
SA Pharmaceuticals). The compound annual growth rate of the market during the 
period 2009 to 2013 was 7.3%. In 2018, the South African pharmaceuticals market 
was forecast to have a value of US $3 billion, an increase of 50% since 2013. The 
compound annual growth rate of the market during the period 2013 to 2018 was 
predicted to be 8.3%. According to the World Health Organisation (WHO), 
pharmaceuticals account for more than 15% of measured global spending on health 
(WHO, 2012). 
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The past 10 years have seen substantial changes in the practice of pharmacy resulting 
from the dynamics arising within industry stakeholders, namely the patient, healthcare 
funder, health care service provider, health professionals and pharmaceutical 
manufacturers, as well as legislative amendments mainly relating to (a) the 
amendment to the Pharmacy Act with respect to pharmacy ownership, which allowed 
non-pharmacist and legal entities to own pharmacies as of 2003, (b) amendments to 
the Medicines and Related Substances Act No. 101 of 1965, introducing a single exit 
price that pharmaceutical manufacturers were to charge wholesalers, which included 
a distribution cost and (c) a pharmaceutical tiered pricing model (Le Roux, 2013). 
The South African Pharmacy Council’s (SAPC) 2015 annual reports indicate statistics 
that reflect a sharp decline in new community pharmacies opened in the last few years. 
From 2010 to 2013 an 80% decrease was observed in the number of new pharmacies 
opened (An increase in the number of pharmacies that closed was also evident, as 
reflected in Figure 1.2.1 (an increase between 2012 and 2013).  
The legislative amendments have had a profound effect on the current pharmacy 
landscape. Over the past four decades the market has been demarcated by an 
increase in product focus, (larger front shop versus a smaller dispensary), rather than 
patient focus. Additionally, there have been increasing trends in the separation of roles 
of the retail pharmacist as medicine supplier and as patient caregiver or 
pharmaceutical care giver. Figure 1.3 reflects the number of corporate pharmacies in 
South Africa. 
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Source: SAPC Annual report, 2015 
Figure 1.2: Representation of community pharmacy trends in South Africa 
 
 
Source: SAPC Annual report, 2016 
Figure 1.3: Provincial distribution of corporate pharmacies (3,316) 
Gauteng is indicated as the province with the most corporate pharmacies, hence the 
choice of a subject sample from the Johannesburg population. 
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1.3 PRIMARY AIM 
The aim of this study was to establish the perceptions of retail pharmacists in 
Johannesburg, Gauteng pertaining to factors influencing the viability of pharmacy 
retail practice and business. 
1.4 RESEARCH OBJECTIVES 
• To explore the experiences as well as the resultant effects of practising retail 
pharmacy in Johannesburg during the last five years. 
• To make recommendations to independent retail pharmacies on overcoming 
the common challenges to best suit the market. 
1.5 OVERVIEW OF THE RESEARCH METHODOLOGY 
Qualitative research was conducted to explore the perceptions, beliefs and emotions 
of the participants. The study utilised five one-on-one, semi-structured interviews with 
independent retail pharmacists in the central, north, south, east and west of 
Johannesburg to explore the said perceptions, beliefs and emotions of retail 
pharmacists regarding their viability. Each interview was expected to take 30 to 45 
minutes and took place by appointment at a venue selected by the interviewee. 
Interviewing continued until data saturation was achieved. 
Participants’ responses were recorded with their prior written consent. The data was 
expressed in words, emotions, ideas and actions and was collected to allow for 
verification and continuity, particularly alignment with the research aim. 
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CHAPTER 2 
RESEARCH DESIGN AND METHODOLOGY 
2.1 INTRODUCTION 
The previous chapter provided an overview of the study in which the research problem 
was identified and the research objective was stated. This chapter presents an in-
depth description of the research design and method followed in this study. 
2.2 RESEARCH DESIGN 
The research design was qualitative, exploratory, descriptive and contextual. 
Qualitative research entails an in-depth introspection of a subject that is not well 
understood or that has been minimally explored (Botma, Greef, Mulaudzi & Wright 
2010:182). The research subject was not quantifiable. Qualitative research was 
utilised to assist the researcher in acquiring detail and substance regarding the 
phenomenon that was lacking in that respect (Botma et al., 2010:182).  There are five 
possible approaches to qualitative research, namely narrative research, 
phenomenology, grounded theory, ethnography and case studies (Lewis, 2015:67-
74).  
Table 2.1 A summary of the five approaches 
Research approach Description 
Narrative research Utilises individual stories to develop 
relevant messages. 
Phenomenology Assists in determining a participant’s 
experience of a topic of interest. 
Grounded theory Identifies causal and intervening 
factors and also the context of a 
particular topic. 
Ethnographies Inform on practices in a cultural 
context. 
Case studies Help draft success stories and are 
used to demonstrate the effectiveness 
of a programme. 
Source: Lewis, 2015:67-74  
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This study was classified as basic research as the application of the research was 
secondary to knowledge generation. It was a design suited for comprehensively 
understanding the phenomenon; the viability of independent retail pharmacists in 
Gauteng (Botma et al., 2010:82). It was thus imperative that the researcher was 
closely involved in gathering the data (Botma et al., 2010:82).  
Quantitative research enables a researcher to closely examine theory generated by 
qualitative research. The aim of this study was to establish the perceptions of retail 
pharmacists regarding factors influencing the viability of pharmacy retail practice and 
business. A broad research undertaking that was expected to produce an overall 
sense of the perceptions of retail pharmacists. The exact causes and detail of the 
perceptions may later be subject to quantitative research. A review of existing literature 
suggested limited research on the topic  
An exploratory research design is an in-depth exploration of the phenomenon under 
study (Botma et al., 2010:189). In this research the phenomenon was the retail 
pharmacists’ perceptions of factors influencing the viability of their practice and 
business. Given that exploration of the topic has been limited, qualitative research was 
ideal as it offered an in-depth investigative opportunity to produce a narrative of the 
topic. The research served to reveal the independent pharmacists’ perceptions of the 
changing pharmaceutical landscape. 
According to Botma et al. (2010:220), in contextual studies the collected data is 
relevant to a specific context (independent pharmacies in Johannesburg), hence 
findings cannot be generalised to other contexts. All qualitative studies are contextual. 
Erlandson, Harris, Skipper & Allen (1993) indicate that much was to be gained by 
looking, listening, feeling and smelling versus routine conversation. Hence the need 
to identify people, location and time should be verifiable by more than one source. 
Merriam’s (1988 observational checklist was a valuable tool as a guide on how to 
structure observation.  
The focus is a single phenomenon that is studied particularly in relation to the context 
of interest. Data contains detailed contextual descriptions of the research. Such detail 
is to include the setting in which the research was undertaken, the participants and 
phenomenon under study as well as the researcher’s personal experiences (Botma et 
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al., 2010:95). The summative characteristics, as detailed, assisted the researcher to 
conceptualise the study and this was important in analysing the research results. 
2.3 RESEARCH METHODOLOGY 
Interviews are a method of collecting data in which qualitative and/or quantitative 
questions can be asked (Doddy & Noonan, 2013:16). The range of interview formats 
includes structured, unstructured and semi-structured interviews (Doddy & Norman, 
2013:25). One-on-one interviews were guided by a semi-structured interview schedule 
to explore the perceptions, beliefs and emotions of retail pharmacists with regard to 
their viability. This is a method used in qualitative research and is ideal for exploring 
the perceptions, beliefs and emotions of participants. Interviews generate contextual 
accounts of participants’ experiences and their interpretation thereof (Schultze & 
Avital, 2011). 
2.3.1 Population 
The Oxford Advanced Learner’s Dictionary (Ashby, 2000) defines a population as a 
well-defined collection of individuals known to have similar characteristics. A 
population can also be defined as an aggregation of cases that meet specified, pre-
determined inclusion criteria in which the researcher is interested (Burns & Grove, 
2005:40). For the purposes of this study, the population comprised independent retail 
pharmacists practising in Johannesburg, Gauteng.  
2.3.2 Sampling method 
Sampling entails selecting a portion of the population to represent the entire population 
and can also be defined as the use of a group of individuals from the stated population 
with whom to conduct the research (LoBiondo-Wood & Haber, 1998:250). One of the 
methods of sampling in qualitative studies is purposive sampling. This was the method 
chosen for this study and is a method of sampling used to achieve a specific purpose, 
such as obtaining information from the specified group regarding their profession and 
business (Maree, 2011:195). The researcher’s prior knowledge of the population was 
used to select individuals with specific characteristics (Botma et al, 2010:201). 
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The sample for this study was five practising retail pharmacists from the central, north, 
south, east and west of Johannesburg. Inclusion criteria were that the sample must 
include independent retail pharmacists who had practised for a minimum of five years 
in Johannesburg, Gauteng. Retail pharmacists with less than 5 years’ experience and 
those who were not involved in the entity’s business management were excluded from 
the study. 
2.4 DATA COLLECTION 
This is the process of gathering and processing information in relation to a topic of 
interest (Ashby, 2000:37), which in this study was exploring factors affecting the 
viability of independent pharmacies in Johannesburg, Gauteng Province. The method 
selected required direct interaction with the subjects (pharmacists) and involved the 
collection of data in a predetermined manner. The study utilised one-on-one, semi-
structured interviews to explore the perceptions, beliefs and emotions of retail 
pharmacists regarding the viability of retail pharmacies. The duration of each interview 
was between 30 and 45 minutes. Interviewing continued until data saturation was 
achieved. 
Interviewing is a method of collecting data in which qualitative and/or quantitative 
questions can be asked (Doddy, 2013:22). A range of interview formats exist that 
includes structured, unstructured and semi-structured interviews (Doddy, 2013:24). 
This study utilised one-on-one interviews guided by a semi-structured interview 
schedule to explore the said perceptions, beliefs and emotions of retail pharmacists. 
Interviews generate contextual accounts of participants’ experiences and their 
interpretation thereof (Schultze & Avital, 2011). Table 2.1 lists the advantages and 
disadvantages of interviews. 
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Table 2.2: Possible advantages and disadvantages of interviews 
Advantages Disadvantages 
• Semi-structured interviews are 
useful to gain insight and context.  
• Assist participants to describe 
what is important to them.  
• Generation of quotes and stories.  
• Enable the researcher to develop 
a rapport.  
• The researcher is able to observe 
as well as listen.  
• Complex questions can be asked.  
• The researcher can explain the 
purpose of the research and 
answer any questions the 
participant may have about the 
study.  
• The researcher can probe the 
participant's responses and seek 
further clarification.  
• Participants can seek clarification 
of a question.  
• They assist the participant to 
provide detailed responses.  
• Can explore participants' reasons 
for acting in a certain way or their 
interpretations of events.  
• Interviews can be a rewarding for 
participants as they stimulate self- 
exploration and discovery.  
• Personal benefit: the telling of 
one's story.  
• May be perceived as intrusive to 
the participant.  
• Time-consuming, in conducting 
the interview and also in relation 
to arranging them, travelling to the 
venue, post-interview 
transcription and analysis of the 
data.  
• Susceptible to bias, which may 
include:  
− the participant's desire to 
please the researcher;  
− saying what they think/feel the 
researcher wishes to hear; 
such as giving an official point 
of view rather than their 
personal view;.  
− the desire to create a good 
impression may lead to 
participants not answering 
honestly;  
− there is a tendency to say 
something rather than nothing 
if the participant cannot 
answer a question or has 
nothing to say on a topic;  
− the researcher's views can 
influence the participant's 
responses by expressing 
surprise or disapproval.  
Source: Doddy & Noonan, 2013 
Semi-structured interviews presented an opportunity for independent pharmacists to 
reflect and narrate their experiences in managing a retail pharmacy. Participants were 
able to vocalise, in discussion, issues and experiences presented to them as 
independent pharmacists. The nature of the interviews allowed for narratives and 
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references to illustrate perspectives. The interviewer had flexibility to probe 
participants further in order to exhaust the topic during the discussion. 
The necessity for interviews was challenging, beginning with securing appointments, 
distances travelled and unwillingness to engage with the topic, as no immediate and 
direct benefits would be realised. The interviewer’s experience and own perspectives 
were difficult to subdue. 
Participants’ responses were recorded, with prior written consent (see consent form, 
Appendix II). Two voice recorders were utilised and the data was subsequently stored 
for safe keeping and for verification and continuity, particularly alignment with the 
research aim. 
2.2.1 Research Questions 
The diminishing number of independent retail pharmacies and the change in the 
pharmaceutical landscape formed the basis of the research. 
The following questions were used as a guide for the interviews that were conducted. 
1. How do you think running an independent retail pharmacy compares with 
running any other retail business? 
▪ Differentiation from other retail businesses 
2. Could you describe any changes you have noticed over the past 5-10 years in 
retail pharmacy trends? 
▪ Degree of rivalry 
▪ Threat of entry 
▪ Threats of substitution 
▪ Supplier power 
▪ Buyer power 
3. Has the provision of pharmaceutical care changed from a professional 
perspective over the past 5-10 years? 
▪ Impact of professional developments, particularly pertaining to the training 
and qualifications of all pharmacy personnel. 
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2.2.1.1 Field notes 
Detailed field notes were written to record that which the researcher experienced and 
encountered whilst conducting the interviews. These reports incorporate a sequence 
of all that the researcher thinks, sees, feels and hears whilst conducting an interview. 
Field notes are particularly useful for data verification, as the researcher recalls the 
details of the interview (Botma et al., 2010:218). An observational protocol that 
comprised three sections was utilised (Creswell, 2009:181-182). These sections 
included descriptive notes (reconstruction of the dialogue and recollection of the 
individual, physical setting), reflective notes that record the researcher’s thoughts as 
well as demographic information that details the time, date and place of each interview 
and the demographics of the participants.  
2.5 DATA ANALYSIS, TRANSCRIPTION AND CODING  
This process entails the dissection and comprehension of the collected data by making 
use of thematic analysis and an independent coder (Ashby, 2000:36). Data is prepared 
(reconstructed) with preliminary coding to allow for ease of reference between 
interviews. The data analysis process is systematic, sequential, verifiable and 
continuous. Observation focuses on the integration of themes, (recurring ideologies 
often linking important findings), patterns and categories in the data that prompt further 
questions (Brink, 2006:55). 
Recognised methods of qualitative data analysis are Cresswell’s method (2009) and 
the interpretive analysis of Terre Blanche, Durrheim and Kelly (2006). Cresswell 
(2009) identified six steps to data analysis. 
  
 14 
 
Source: Adapted from Cresswell 2009 
Figure 1.3: Provincial distribution of corporate pharmacies (3,316) 
For the purposes of this study, Cresswell’s method was applied to the data analysis. 
Data analysis was undertaken after the interviews following the transcription of the 
voice recordings. Themes were determined with the assistance of an independent 
coder. Researcher bias that could compromise the rigour of the study was eliminated 
by the use of inter-observer comparisons. The presence of two observers per interview 
can also eliminate potential bias (Bowling, 2002:362). 
2.6 PILOT STUDY 
Pilot studies, also known as 'feasibility' studies, are mini versions of a full-scale study, 
as well as the specific pre-testing of a particular research instrument such as an 
interview schedule or questionnaire (Ashby, 2000:880). It is an important element of a 
study design and increases the likelihood of a successful study. Pilot studies fulfil a 
range of important functions, providing insight into an appropriate sample size and 
improving the study design and can provide valuable insights for other researchers 
(van Teijlingen & Hundley, 2001).  
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Pilot studies also detect possible shortcomings in the study design, identify unclear 
items in the questionnaire and provide feedback regarding the wording, information 
and structuring of the questionnaire (Welman & Kruger, 1999:146). 
One interview served as the pilot study for the research that was to be undertaken. 
The interview was deemed to be successful. The results of the pilot study were 
therefore included in the final study. The pilot study, as a proactive approach, served 
as a means of validating the instrument that was chosen (semi-structured interviews) 
as a means to reduce error. The results were used to identify and correct any errors 
before they were built into the final research instrument (Morse, 2002). 
2.7 VERIFICATION OF DATA 
Guba's (1981) model of trustworthiness, which describes four general criteria for the 
evaluation of research from both a quantitative and a qualitative perspective, was 
applied. The four general criteria are credibility (internal validity), transferability 
(external validity), dependability (reliability) and confirmability (objectivity) (Thomas & 
Kathy, 2011:151-155). Within these criteria are specific methodological strategies for 
demonstrating qualitative rigour, such as the audit trail, checks when coding, 
categorising, or confirming results with participants (pharmacists), peer debriefing, 
persistent observation, negative case analysis, structural corroboration and referential 
material adequacy (Thomas & Kathy, 2011:151-155). 
2.8 ETHICAL CONSIDERATIONS 
Research is subject to ethical standards that promote and ensure respect for all 
subjects (as well as the profession) and protect participants’ rights. Research must be 
conducted in a manner that minimises disruption to the practice of pharmacy.  
The Declaration of Helsinki (2000) states that every precaution is to be taken to protect 
the privacy of research subjects and the confidentiality of their personal information. 
The pharmacists (subjects) had to be adequately informed of the aims, methods and 
sources of funding, any possible conflicts of interest and institutional affiliations of the 
researcher (Nelson Mandela University), the anticipated benefits and potential risks of 
the study and the discomfort it could entail, as well as any other relevant aspects of 
the study. The potential subjects were informed of their right to refuse to participate in 
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the study or to withdraw consent to participate at any time without reprisal. Subjects 
were given the option of being informed about the general outcome and results of the 
study as well as the dissemination thereof (World Medical Association, 2016). 
In addition, in line with the Nuremberg Code (1947), volunteers were afforded the 
opportunity to participate in the research, to withdraw should they choose to and 
protection from harm during, or as a result of, the study. Justice was upheld at all times 
in the interest of the participants. All participants were informed of the purpose of the 
research, the role of the interview in the research, the time required as well as being 
assured of the confidentiality of the information discussed during the interview. (The 
informed consent form is attached as Appendix II). 
The research intended to uphold all guidelines in accordance with all professional ethic 
codes, for example those in the National Health Research Ethics Council Guidelines 
and the Department of Health, as well as the Guidelines for Good Clinical Practice 
(GCP). 
In accordance with professional ethical codes, semi-structured interviews were 
conducted within a population of suitable independent retail pharmacists in 
Johannesburg. Verification of the data was guided by Guba’s model of 
trustworthiness. The pilot study was instrumental in conducting subsequent interviews. 
Bias was minimised in the analysis, transcription and coding of the data by making 
use of an independent coder. The research design (qualitative, exploratory, 
descriptive and contextual) was thus implemented successfully. 
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CHAPTER 3 
DISCUSSION OF INTERVIEW FINDINGS 
3.1 INTRODUCTION 
The study of the perceptions of retail pharmacists with regard to the viability of retail 
pharmacy in Johannesburg, Gauteng was conducted through 6 (5 + 1 pilot) semi-
structured, one-on-one interviews with independent pharmacists practising in north, 
east, west, south and central Johannesburg. The research design was qualitative, 
exploratory, descriptive and contextual, a design used in qualitative research for 
exploring the perceptions, beliefs and emotions of participants. Interviews generate 
contextual accounts of participants’ experiences and their interpretation thereof 
(Schultze & Avital, 2011:4). 
All qualitative studies are contextual. Erlandson et al. (1993) hold that much is to be 
gained by looking, listening, feeling and smelling versus routine conversation, hence 
the need for people, locations and times to be verified by more than one source. Thus, 
the decision to sample from the five geographical points of Johannesburg was upheld. 
This study was classified as basic research as application of the research was 
secondary to knowledge generation. It was a design suited for comprehensively 
understanding the phenomenon under investigation (the viability of independent retail 
pharmacists in Gauteng) (Botma et al., 2010:82). A preliminary interview served as a 
pilot study. 
The aim of this study was to establish the perceptions of retail pharmacists and to 
identify factors influencing the viability of retail pharmacy practice and business. The 
research objectives were to: 
• explore the experiences and resultant effects of practising retail pharmacy in 
Johannesburg for the past five years and 
• make recommendations to independent retail pharmacies on overcoming the 
common challenges to best suit the market. Participants were qualified retail 
pharmacists who had practised in this capacity for a minimum of five years in 
the Johannesburg, Gauteng region of South Africa. Retail pharmacists with less 
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than five years’ experience and those who were not involved in the entity’s 
business management, were excluded from the study. 
The interview at Johannesburg South was conducted with Participant One. He had 
been practising at the same address as an independent retail pharmacist for more 
than 10 years and had managerial experience. His tenure as a retail pharmacist thus 
provided feedback worth noting.  
Johannesburg East interviews were conducted with two retail pharmacists, one having 
practised inside a shopping centre and the other not. Participant Two was registered 
with 34 years’ experience in managing a retail pharmacy. The second participant from 
this area was designated as Participant Three and had a career as an independent 
retail pharmacist spanning more than 25 years. 
Johannesburg West was represented by Participant Four, a registered independent 
pharmacist with approximately 6 years’ experience at the same location and a further 
9 years at various other locations.  
The interview for Johannesburg Central was held with Participant Five, an 
independent retail pharmacist who had also attended short courses in business 
management. 
Lastly, the interview in the north of Johannesburg was conducted with Participant Six 
who was not a pharmacy owner but was involved in various business aspects of the 
pharmacy. He was a registered retail pharmacist with more than 7 years’ experience. 
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Table 3.1: Summary of participants 
Participant 
Location in 
Johannesburg 
Qualification 
Other 
learning 
activities 
Years of 
relevant 
experience 
1 Johannesburg South B.Pharm none ≥ 10 Years 
2 Johannesburg East Dipl.Pharm none ≥ 34 Years 
3 Johannesburg East Dipl Pharm none ≥ 25 years 
4 Johannesburg West B.Pharm none ≥ 9 Years 
5 
Johannesburg Central B.Pharm Short 
business 
courses 
≥ 7 years 
6 Johannesburg North B.Pharm none ≥ 7 Years 
Registration details of the participants were provided but have not been included in 
the report in the interest of confidentiality. 
3.2 THEMES AND SUB-THEMES IDENTIFIED  
The following themes and sub-themes were identified. 
1. Legislative changes impact negatively on the viability of independent 
pharmacies. Sub-themes for this theme were: (i) entry of corporate pharmacies 
into the retail pharmacy space; (ii) retail pharmacies’ ownership by pharmacy 
wholesalers; (iii) pharmaceutical industry that determines prices, with price 
fixing as a disadvantage to independent pharmacists and (iv) independent 
pharmacies lack support from government 
2. Medical aids’ funding structures are a challenge. The related sub-themes 
were: (i) designated service providers (DSPs) are a cause of a decreased 
customer base leading to unfair competition with no protection for independent 
pharmacies and (ii) doubts regarding the legality of DSPs and courier 
pharmacies. 
3. Pharmaceutical care highlighted as a prospective growth area. This is 
because independent pharmacies are not financially viable with a low return on 
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investment. Sub-themes include: (i) approval and marketing of in-house 
brands; (ii) failure to increase dispensing fee; (iii) unfair advantage for corporate 
pharmacies in economies of scale and (iv) corporates increasing focus on the 
retail element versus professional service provision, thus creating a need to 
push volumes to be financially viable. 
Table 3.2: Summary of themes and sub–themes identified 
CATEGORIES OF 
THEMES FOR 
DISCUSSION 
SUB-THEMES 
1. Legislative 
changes 
(i) Entry of corporate pharmacies into the retail pharmacy 
space. 
(ii) Retail pharmacies’ ownership by pharmacy wholesalers. 
(iii) Pharmaceutical industry that determines prices, with price 
fixing that disadvantages independent pharmacists.  
(iv) Independent pharmacies lack support from government 
2. Medical aid 
funding 
structure 
challenge 
(i) Designated service providers (DSPs) are a cause of a 
decreased customer base leading to unfair competition 
with no protection for independent pharmacies.  
(ii) Doubts regarding the legality of DSPs and courier 
pharmacies. 
3.Pharmaceutical 
care as a 
prospective 
growth area 
(i) Approval and marketing of house brands.  
(ii) Failure to increase dispensing fees.  
(iii) Unfair advantage for corporate pharmacies in economies 
of scale.  
(iv) Corporates’ increasing focus on retail element versus 
professional service provision, thus creating a need to 
push volumes to be financially viable. 
Each of these themes will now be discussed through their sub-themes. 
3.3 DISCUSSION OF THEMES AND SUB-THEMES 
3.3.1 Theme 1: Legislative Changes 
According to the Pharmacy Act, as amended, retail pharmacies in South Africa are 
licensed entities in which compounding, counselling and dispensing of medicinal 
substances occurs under the supervision of a registered pharmacist. 
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On 25 April 2003 the Minister of Health, in consultation with the South African 
Pharmacy Council and in terms of Sections 22 and 22A of the Pharmacy Act, passed 
regulations relating to the ownership and licencing of pharmacies. Any person may, 
subject to the provisions of Regulation 7, own or have a beneficial interest in a 
community pharmacy in the Republic of South Africa. This decision heralded the entry 
of several new participants in the marketing space, most notable being the macro 
community pharmacies also referred to as corporate pharmacies (Gilbert, 1998). 
These macro pharmacies were characterised by their supersized front shops and 
discounted cash prices on retail products. As reflected in the interviews, a marked 
change was observed in the pharmacy landscape with respect to the practice of retail 
pharmacy. Four of the five participants alluded to this statement. Participants stated 
that the corporate pharmacies’ wholesale shopping experience was welcomed by 
consumers at the cost of compromising pharmaceutical care. These entities were 
viewed as responsible for commercialising the practice of pharmacy. Participant Four 
said: “The biggest mistake was allowing non-pharmacists to own pharmacies. Every 
tier has contributed, from government to Pharmacy Council.” 
Figure 3.1 reflects the distribution of corporate pharmacies throughout the nine 
provinces of South Africa. Gauteng is reported to have the largest number of corporate 
pharmacies to date. 
 
Source: SAPC 2016 Annual report 
Figure 3.1: Distribution of Corporate Pharmacies by Province 
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Porter’s five forces framework, (Competitive Strategy: Techniques for Analyzing 
Industries and Competitors, 1980), relates the average profitability of participants in 
an industry to five competitive forces, namely: 
• degree of rivalry;  
• threat of entry;  
• the threat of substitutes;  
• buyer power and 
• supplier power. 
Participants expressed the view that there were negative effects due to the resultant 
degree of rivalry between independent and corporate pharmacies. The corporate 
pharmacies’ buying power and supplier power, in comparison to the independent 
pharmacy, afforded these establishments the upper hand, as economies of scale 
determined the end cost, particularly with respect to non-professional products (front 
shop items). Participant Two stated “Well, you know how they are making it. Buying 
power and selling things that are not related to pharmacy. If you walk into a Dischem 
you will see a dispensary right at the back.” 
The introduction of courier pharmacies, (retail pharmacies whose business is sending 
prescription medicines to patients by post or courier), heralded a new era in pharmacy 
practice. Medicine users were offered an alternative option of filling their prescriptions. 
The prescriptions would be forwarded to a registered dispenser who in turn couriered 
the prescribed medicine to the patient. Thus, the patient did not require to step into a 
pharmacy. Concern arose with the limited patient-pharmacist interaction, as what little 
there was revolved around drug utilisation reviews conducted in line with the relevant 
funder’s payment rules and restrictions. Storage of drugs in transit, patient counselling 
and pharmacy practice were aspects of much contention within the industry, as 
expressed by the research participants.  
Participant Two explained “My biggest problem with those is there is no counselling, 
no opportunity for the patient to be like this is what is happening to me? It seems I get 
a different medicine every month, it’s the same ingredient you know and when it’s out 
of stock they just give the next ingredient without explaining. They come in here all 
day long and they are like ‘What is this for, I haven’t taken it for a month because it’s 
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not the right thing’ and you are like it is the right thing but they say it doesn’t look the 
same”. 
Dispensing medical doctors create the threat of substitutes that eliminates the need to 
use a retail pharmacy. The regulation in which doctors were permitted to dispense 
medication under specified conditions came into effect in 2003 (Medicines and 
Related Substances Act 101, 1965). Participant Four alluded to the effect of 
dispensing doctors. 
A pricing committee set up by the minister of health was introduced in 2004 that 
introduced:  
• a single exit price (SEP); 
• tiered dispensing fees and 
• amendments to logistics fees charged by pharmaceutical 
wholesalers/distributors. 
The introduction of the SEP eliminated pricing incentives previously introduced with 
bulk purchases and other marketing drives. Tiered dispensing fees are based on the 
value of the product, the higher the value (usually innovator products) the less the 
dispensing fee and vice versa. This was proposed to encourage growth in the generic 
medicine market.  
Participant Three argued: “There’s a big change! Let me tell you something, your profit 
margin that time was 50% you could make a good living, your profit margin now is 
about 12 to 14%. How could you survive on that percentage? You see these idiots that 
don’t understand the efficacy of running a business. They don’t understand. They say 
you work on this margin or that margin.” 
Questions were raised about the appropriateness of remuneration models for these 
mandatory duties associated with dispensing that affected the long-term financial 
viability of relevant service providers. It has been suggested that remuneration models 
need to reflect an appreciation of pharmacists. Participants complained that there has 
not been an increase in years. 
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In a survey of 200 pharmacists (22% in public employment and 78% in private) 
conducted by Gerhard Joubert, Head of Group Marketing and Stakeholder Relations 
at PPS, 86% of the respondents felt threatened by the growing number of corporate 
retail pharmacies and 91% stated that they did not believe current legislation caters 
sufficiently for the needs of pharmacists (Joubert, 2015). 
3.3.2 Theme 2: Medical Aids’ Funding Structure Is A Challenge.  
A feature of the Medical Schemes Act is prescribed minimum benefits (PMB), which 
can be described as a set of defined benefits to ensure members have access to 
certain minimum health benefits (Councilf for Medical Schemes, 2018). Medical aids 
are obligated to cover the costs related to the diagnosis, treatment and care of these. 
The chronic disease list (CDL) specifies medication and treatment for 25 chronic 
conditions covered under the PMBs, (refer to Appendix VI for the complete list of 
conditions), as detailed under the Medical Schemes Act. 
South Africa’s disease profile is described as a ‘quadruple burden of disease’, namely 
a high prevalence of HIV and AIDS, which is linked with tuberculosis, increased 
maternal and child morbidity and mortality, increased prevalence of non-
communicable diseases, mostly driven by risk factors related to life-style and finally, 
violence, injuries and trauma (StatsSA, 2014).  
Designated service providers are healthcare service providers (doctor, pharmacist, 
hospital and other healthcare service providers) that are a medical scheme’s first 
choice when its members require diagnosis, treatment or care for a PMB condition 
(Council of Medical Schemes, 2018). The cost of PMBs is reported to have increased 
by 13% from R556 in 2014 to R608 per beneficiary per month in 2015. The question 
posed by Participant Four concerned the link between the prevalence of the listed 
conditions with the actual disease profile of South Africa. The general consensus was 
that the list is misleading and does not reflect the true remunerable chronic base as it 
presents. Participant Five stated “The most common diseases we see are only a 
handful.” 
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Source: Council of Medical Schemes, 2017 
Figure 3.2: Prevalence of chronic conditions 
Participants cited challenges in the way DSPs operate in the retail pharmacy sphere. 
The main issues highlighted were agreements entered into by medical aids with mainly 
corporate pharmacies, which served to lock in a: 
• minimum percentage mark-up in favour of the medical aid and 
• customer base in favour of the pharmacy. 
Participant Two argued “In our case it’s unique technically we not trying to undercut, 
they are not undercutting us they are selling it at 26% and say we are prepared to 
selling at 26 why are they stopping us”. 
The SEP introduced in 2004 is applicable to medicines sold in the private sector. This 
is the price at which a manufacturer must sell to all pharmacies, irrespective of volume 
sold. The SEP applies to medicines that can only be bought in a pharmacy (Pampel, 
2013). 
The legislated pricing schedule dictates that pharmacies apply a maximum product 
mark-up fee of 36% with no minimum expressed. The professional fee element of the 
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remuneration is affected through a tiered dispensing fee model that is based on the 
value of the product, as stated above (the higher the value the less the dispensing fee 
and vice versa). Participants expressed frustration at the low percentage mark-up 
offered by funders within a DSP arrangement and believed this is only possible for 
retail pharmacies whose core business is not dispensing medicine. Such 
arrangements were believed to favour the designated service provider by ensuring a 
consistent client base.  
Participant Two stated “You get a customer saying sorry I can’t buy from here 
anymore. Now that means when he came and got his script and picked up whatever 
he wants, Syndols® or something with it, it’s all gone because they just don’t come 
here anymore so there’s no spin offs on whatever he bought when he went to the till 
if he wanted to buy a chocolate or something. We’ve lost all of that.” 
Designated service providers/medical aid arrangements are exclusive to specific 
corporate retail pharmacies and often exclude independent pharmacies. Participants 
considered this an unfair practice, as all retail pharmacists should be afforded an 
opportunity to become a DSP despite the unacceptable low rates medical aids are 
willing to pay in these arrangements. An outcry to the government for failing to protect 
independent pharmacies was made by the participants who questioned the legality of 
these arrangements. Participant Three asked “Why are DSPs even legal?” Participant 
Two shared that his chronic patient script count had decreased by as much as 80% 
due to medical aid DSP arrangements.   
The Independent Community Pharmacy Association (ICPA) has embarked on a 
campaign to challenge DSP arrangements as well as the calculation of penalty co-
payments levied on services obtained from service providers that have no DSP 
arrangements with the funder. As part of the campaign, the ICPA has also called on 
the public to voice an opinion on the practice of closed DSPs. 
Medical aid members opting to utilise the services of a non-DSP retail pharmacy are 
penalised (up to 20% of the cost of the prescription), which may act as a deterrent by 
having to pay a portion of the total cost of their prescription. This resulted in a 
diminished customer base for non-DSP retail pharmacies. The ICPA holds that its 
engagement with the Council of Medical Schemes has resulted in prioritisation of the 
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practice of DSP business arrangements (Independent Community Pharmacists’ 
Association (ICPA), 2017). 
Designated service provider arrangements were accused of being responsible for the 
growth of courier pharmacies. Courier pharmacies dispatch medicine by post or other 
delivery means to customers according to medical aid specifications. This results in 
fewer customers collecting their prescriptions from retail pharmacies, thus reducing 
potential business. The appointment of designated service providers is contrary to 
public interest; it destroys the pharmaceutical healthcare footprint and undermines the 
delivery of primary healthcare (ICPA, 2017).  
Participant Three said: “It cannot be accepted that the general public is twisted to 
specific service providers at the cost of their wellbeing. I mean, look at how 
disempowered these patients become.” 
3.3.3 Theme 3: Pharmaceutical Care As A Prospective Growth Area 
The World Health Organisation (WHO) introduced the concept of a seven-star 
pharmacist (see Figure 3.3), a multi-functional role encompassing caregiver, 
communicator, decision-maker, life-long teacher, leader and manager. Participants 
described these roles as the key differentiators between corporate pharmacies and 
independent pharmacies. Participant Four explained “Pharmacists practising 
pharmaceutical pharmacy offer more than retailers where customers are just a 
number”. 
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Source: World Health Organisation (WHO),  Wiedenmayer, Summers, Mackie, 
Gous, Everard & Tromp, 2006:16 
Figure 3.3: Seven-star concept of a pharmacist 
Pharmacy as a profession defines itself as a patient-focused profession as opposed 
to a general view of a product-for-profit profession (Williams, 2006:219). 
Pharmaceutical care was loosely identified as the vehicle to achieve a large number 
of the ideals mentioned above. Participants were of the opinion that a focus on the 
elements that truly define the profession may be the answer to an improved future for 
independent retail pharmacists. Concerns were raised over the minimal attention 
given to the roles of communicator, caregiver and teacher, as evident in the business 
models of corporate courier pharmacies.  
Participant Three expressed his opinion by saying: “You see the reason they come to 
a community pharmacy, all the years;” “You speak to them, their kids were small, they 
growing up, they ask advice. A Dischem has got a Mr van Tonder there next day Mr 
van der Merwe following day Mrs Pampapoer following day this pharmacist. You can 
never correlate everyone together and get a relationship with somebody.” 
Failure by the government to fairly increase pharmacist professional fees was 
confirmation of a poor recognition of pharmaceutical care provision. The participants 
felt that dispensing fees had been minimally increased since inception. A participant 
stated “…and also getting it back to money and business, we’ve had the same 
dispensing fee since.” Participant Two added: “This year we’ve had 1% in medicine 
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how can that possibly be allowed when we have an inflation rate of 6% and then they 
give us a 1% in medicine.” 
Table 3.3: Gazetted dispensing fee amendments (National Health Plan 
Strategy, 2018) 
 
The figures depicted above were not welcomed and were viewed as the reason 
independent retail pharmacy had become a questionable investment. Participant 
Three declared his intentions not to renew the rental lease because of the poor 
remuneration schedule, whilst Participant One stated that he had strong reservations 
on future income streams through independent pharmacy. Participant One explained, 
“I was actually telling someone that as it stands I am trying to salvage whenever I can; 
I probably should jump. I don’t think I can renew the lease twice, probably I will sit for 
the last year and scramble what I can then take what I can and re-invest somewhere.” 
The Pharmaceutical Society of South Africa states that a pharmacist’s main income 
should be derived from providing services rather than trading in medicine (Healthcare 
report, 2000). However, this was contrary to the experiences of the participants.  
Participant Three said “There’s a big change! Let me tell you something your profit 
margin that time was 50% you could make a good living, your profit margin now is 
about 12 – 14%. How could you survive on that percentage? You see these idiots that 
don’t understand the efficacy of running a business. They don’t understand.” He added 
“They say you work on this margin or that margin.” 
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Worthen (2006:235), following through on the Millis Study Commission’s report of 
1975, stated that pharmacies should be recognised as a source of healthcare 
information. Pharmaceutical care in retail pharmacy encompasses drug utilisation 
review, disease management, collaborative practice and pharmacogenomics 
(Worthen, 2006:235). 
A growing trend by corporate pharmacies is the marketing of in-house brands. This 
practice skewed the playing field, as it could provide the corporate an additional 
revenue stream and endorsed the product-based pharmacy practice approach. The 
green list campaign initiated by one of the corporate pharmacies is aimed at promoting 
specific brands of products above others in line with agreements secured with related 
manufacturers. A call for a review of such conduct and of registration of ethical 
products by corporate pharmacies was made. Participant One questioned: “I mean 
how did they allow retail pharmacies to own wholesalers?” 
3.4 RESEARCHER’S SUMMARY 
The general tone of the interviews was largely despondent with a slight glimmer of 
hope. Participants concurred that the retail pharmacy landscape had undergone 
significant changes. Changes identified were neither in favour of independent retail 
pharmacists nor the profession of pharmacy in its entirety. 
The identified themes continued throughout the interviews and suggested a fair 
representation of the views of the independent pharmacy community at large.  
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CHAPTER 4 
CONCLUSIONS, LIMITATIONS AND RECOMMENDATIONS 
4.1 INTRODUCTION 
The study aimed to establish the perceptions of retail pharmacists in Johannesburg 
based on factors influencing the viability of pharmacy retail practice and business. A 
study of literature pertaining to retail pharmacy practice in South Africa within the 
context of professional pharmacy practice and that of business management was 
instrumental in guiding the fundamental elements of this research. Business studies 
undertaken on profitability, sustainability and business analysis provided objectivity in 
exploration of the aim. The Pharmacy Act outlined the legal framework within which 
the business of a retail pharmacy is conducted in South Africa.  
Chapter 1 described the overview of the study and indicated the aims, objectives and 
rationale for the study. Chapter 2 provided an in-depth description of the research 
methodology followed by an exploration and discussion of the research findings in 
Chapter 3. 
4.2 CONCLUSIONS 
Factors identified in the study highlighted the influence of legislative amendments on 
pharmacy practice. The impact of changes in ownership of retail pharmacies resulted 
in the entry of corporate pharmacies, which have been perceived by retail pharmacists 
as disadvantaging factors. Pricing regulations minimised income potential, whilst 
medical aids’ funding structures further compromised the income of retail pharmacists 
by reducing the payable mark-up on medicinal products. Exclusive business 
arrangements between medical aids and selected retail pharmacies further challenged 
the retail pharmacy market.  
The business model of a courier pharmacy was interpreted as negating 
pharmaceutical care, as it was perceived to discredit the practice of pharmacy. 
Diminishing pharmaceutical care increased the need for professional interpersonal 
interaction. Independent retail pharmacies, with adequate government support, are 
possibly in a position to fulfil that need. Retail pharmacists are likely to be the best 
 32 
source of pharmaceutical care and are thus able to maximise public need with the 
hope of improving turnover. 
4.3 LIMITATIONS OF THE STUDY 
Minimal literature could be located on the exploration of the relationship between the 
legislative framework and the business elements and success. The business acumen 
and training of the retail pharmacists interviewed were not engaged as a variable in 
the research. 
The study could have benefitted from exploring the views of other stakeholders in retail 
pharmacy, such as medical aids, courier and corporate pharmacists, as well as the 
general public on the viability of retail pharmacies. Additional input by the stakeholders 
could assist in obtaining a more informed perception of the viability of retail pharmacies 
in Johannesburg as well as perceptions throughout South Africa. 
4.4 RECOMMENDATIONS 
1. An in-depth, nation-wide exploration of independent retail pharmacists’ 
shortcomings and successes. 
2. Recommendations for accredited pharmacy business management training. An 
addition to the final year curriculum of the Bachelor of Pharmacy qualification 
focusing on business analysis, managerial skills and financial management, 
reinforced by an internship programme in retail pharmacy would empower retail 
pharmacists to run more viable retail pharmacies. 
3. Engage the portfolio of health committee in parliament to address the 
diminishing practice of pharmaceutical care. 
4.5 CONCLUDING REMARKS 
Retail pharmacists have a multi-faceted responsibility to be healthcare professional 
service providers, educators, gate-keepers of medicinal products and the additional 
responsibility to ensure the viability of the business entity. Hindrances encountered by 
retail pharmacists to balancing these responsibilities and to successfully marry them 
are a challenge for retail pharmacists. A middle ground, beneficial to all areas of their 
responsibilities is therefore an ideal to strive towards. The pharmaceutical retail 
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industry needs to recognise the issues and the lessons inherent in their service to 
improve future retail pharmacy prospects. 
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APPENDIX I: RESEARCH METHODOLOGY 
This study will utilise the one-on-one interviews guided by a semi-structured interview 
schedule to explore the said perceptions, beliefs and emotions of retail pharmacists 
on the viability of retail pharmacists 
A method used in qualitative research ideal for exploring perceptions, beliefs and 
emotions of participants. This study will utilise the method to explore the said 
perceptions, beliefs and emotions on viability of retail pharmacies in one- on- one 
interviews guided by a semi-structured interview schedule. 
Population 
The Oxford Advanced Learner’s Dictionary (2000) defines a population as a well-
defined collection of individuals known to have similar characteristics. For the 
purposes of this study the number of pharmacists in retail pharmacy practice in 
Gauteng is reported as 1096 (South African Pharmacy Council, April 2016)  
Sampling method 
Sampling entails selecting a portion of the population to represent the entire population 
and can also be defined as the use of a group of individuals, from the stated 
population, with whom to conduct the research (LoBiondo-Wood & Haber 1998:250) 
One of the methods of sampling in qualitative studies is purposive sampling which is 
the chosen method for this study. 
The sample size for this study is 5 practising independent retail pharmacists in 
Johannesburg who meet the inclusion criteria. Inclusion criteria are that the 
pharmacists must have been working in retail pharmacy for a minimum period of 5 
years, in the Johannesburg, Gauteng region. 
Data collection 
 This is the process of gathering and processing information in relation to a topic of 
interest: Factors affecting the viability of Independent pharmacies in Johannesburg, 
Gauteng. The method selected, requires direct interaction with the subjects 
(pharmacists) and involves collecting of data in a pre-determined manner. The current 
study will utilise scheduled semi-structured interviews with 5 participants and may 
continue until data saturation is achieved. 
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Participants’ responses will be recorded, with prior written consent. Two voice 
recorders will be utilised and the data will be subsequently stored for safekeeping. It 
is expected that data will be expressed in words, emotions, ideas and actions that will 
be collected to allow for verification and continuity particularly in-line with the research 
aim. 
Research Questions 
The following will be used as a guide to the interview: 
1. How would you compare running an independent retail pharmacy with running 
a different retail business? 
2. Has there been a change in retail pharmacy business trends in the last 5 -10 
years? 
3. What changes have you noted in pharmaceutical care provision? 
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APPENDIX II: INFORMATION AND INFORMED CONSENT FORM 
NELSON MANDELA METROPOLITAN UNIVERSITY 
INFORMATION AND INFORMED CONSENT FORM 
RESEARCHER’S DETAILS 
Title of the research project 
Retail pharmacists’ perceptions of factors influencing the viability of their practice 
and business in Johannesburg, Gauteng province. 
 
Reference number H18-HEA-PHA-001 
Principal investigator Nondumiso Sybil Gazi 
Address 4A Millard Road, Bedfordview  
Postal Code 2007 
Contact telephone number 
(private numbers not advisable) 
+27 721558337 
 
A. DECLARATION BY OR ON BEHALF OF PARTICIPANT  Initial 
I, the participant and the 
undersigned 
 
(full names) 
  
ID number  
Address (of participant)  
 
 
A.1 HEREBY CONFIRM AS FOLLOWS:  Initial 
I, the participant, was invited to participate in the above-mentioned research project   
that is being undertaken by Nondumiso Gazi 
from Faculty of Health Sciences 
of the Nelson Mandela University. 
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 THE FOLLOWING ASPECTS HAVE BEEN EXPLAINED TO ME, THE 
PARTICIPANT: 
 
Initial 
2.1 Aim:   
The aim of this study is to establish perceptions of retail 
pharmacists; in Johannesburg, Gauteng; on factors influencing 
the viability of pharmacy retail practice and business. 
  
   
2.2 Procedures:   
I understand the procedures to be followed when participating 
in the study. 
  
2.3 Risks: 
No known risks, as an individual, retail pharmacist and or 
business owner are anticipated, to the participant. 
  
2.4 Possible benefits:   
As a result of my participation in this study, recommendations to 
improve the viability of independent retail pharmacies 
  
2.5 Confidentiality:   
My identity will not be revealed in any discussion, description or 
scientific publications by the investigators. 
  
2.6 Access to findings: 
Any new information or benefit that develops during the course 
of the study will be shared as follows: 
  
2.7 
Voluntary 
participation / refusal 
/ discontinuation: 
My participation is voluntary YES NO   
My decision whether or not to 
participate will in no way affect my 
present or future care / employment / 
lifestyle 
TRUE FALSE 
 
3. THE INFORMATION ABOVE WAS EXPLAINED TO ME/THE PARTICIPANT 
BY: 
 
Initial 
Nondumiso Gazi   
in   English      
and I am in command of this language, or it was satisfactorily translated to me by 
(name of translator) 
I was given the opportunity to ask questions and all these questions were answered satisfactorily. 
 
4. 
No pressure was exerted on me to consent to participation and I understand that I may 
withdraw at any stage without penalisation. 
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5. Participation in this study will not result in any additional cost to myself.   
 
A.2 I HEREBY VOLUNTARILY CONSENT TO PARTICIPATE IN THE ABOVE-MENTIONED 
PROJECT: 
Signed/confirmed at  on  20 
  
 
B. STATEMENT BY OR ON BEHALF OF INVESTIGATOR(S) 
I,  Nondumiso Gazi declare that: 
1.  
I have explained the information given in this 
document to 
(name of patient/participant) 
and / or his / her representative (name of representative) 
2. He / she was encouraged and given ample time to ask me any questions; 
3. 
This conversation was conducted 
in 
  English      
And no translator was used OR this conversation was translated into 
(language)  by (name of translator) 
4. 
I have detached Section D and handed it to the 
participant YES NO 
Signed/confirmed 
at 
 on  20 
Signature of interviewer 
Signature of witness: 
Full name of witness: 
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C. DECLARATION BY TRANSLATOR (WHEN APPLICABLE) 
I,  (full names) 
ID number  
Qualifications and/or  
Current employment  
confirm that I: 
1. Translated the contents of this document from English into (language) 
2. 
Also translated questions posed 
by  
(name of participant) 
as well as the answers given by the 
investigator/representative; 
3. Conveyed a factually correct version of what was related to me. 
Signed/confirmed at  on  20 
I hereby declare that all information acquired by me for the purposes of this study will be kept confidential. 
Signature of translator 
Signature of witness: 
Full name of witness: 
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D. IMPORTANT MESSAGE TO PATIENT/REPRESENTATIVE OF PARTICIPANT 
 
Dear participant/representative of the participant 
 
Thank you for your/the participant’s participation in this study.  Should, at any time during the study: 
 
- an emergency arise as a result of the research, or 
- you require any further information with regard to the study, or 
- the following occur 
 
 
 
 
 
 
 (indicate any circumstances which should be reported to the investigator) 
 
Kindly contact Nondumiso Gazi 
 
 
 
 
at cellphone number 
and email address 
+27 795256623; s215293908@nmmu.ac.za                                                               
xxx                                                                                                
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APPENDIX III: INVITATION TO PARTICIPATE ON STUDY 
 
  
  
  
   
 
 
 
 
Summerstrand Campus 
Faculty of Health Sciences 
Tel . +27 (0)41 504 3946    
s215293908@nmmu.ac.za      
Date January 2018 
Ref:  215293908 
Contact person:  Nondumiso Gazi 
Study Title 
Retail pharmacists’ perceptions of factors influencing the viability of their practice and 
business in Johannesburg, Gauteng province 
Dear Retail Pharmacist 
My name is Nondumiso Gazi. I am a registered pharmacist and a student enrolled for 
a Master’s degree in Health and Welfare Management (Student number: 215293908) 
at the Nelson Mandela University. For the purposes of the degree I am conducting a 
study to establish how the pharmacy model is changing and how that change has 
been perceived by independent retail pharmacists in Johannesburg, Gauteng. 
The objectives of the research are:  
1. To explore experiences as well as resultant effects in practising retail 
pharmacy, in Johannesburg, for the last five years. 
2. To make recommendations to independent retail pharmacies on overcoming 
the common challenges to best suit the market 
Participation in the research involves submitting to an interview, the results of which 
will form a collective representation of the perceptions of retail pharmacists on the 
changing pharmacy model. Results will be made available to you and will be 
 45 
disseminated within the university and other academic structures including peer 
reviewed journals. 
The study will be undertaken under the supervision of two members of Nelson 
Mandela University staff and with the approval of the University’s Ethical Committee 
(H18-HEA-PHA-001). 
I invite you to participate in this study. Your identity will not be revealed and withdrawal 
shall not result in any known consequence/s. 
Yours sincerely 
 
Ms N Gazi 
Contact details in the event of enquiries: 
Ms N Gazi (s215293908@nmmu.ac.za; 0721558337) 
                                                                                                                    
Ms AG Klopper (supervisor)   Dr BC Knoesen (co-supervisor) 
aileenk @absamail.co.za;    Brent.Knoesen@mandela.ac.za 
Telephone: 061 9695364  Telephone: 074 3209463 
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APPENDIX IV: THIRD INTERVIEW 
Retail pharmacists’ perceptions of factors influencing the viability of practice 
and business in Johannesburg, Gauteng province 
Date: 30 May 2018 
Time: 13.32 
 
Introduction: As per the paperwork/letter handed to the subject 
The following were used as a guide to the interview: 
1. How would you compare running an independent retail pharmacy with running 
a different retail business? 
2. Has there been a change in retail pharmacy business trends in the last 5 -10 
years? 
3. What changes have you noted in pharmaceutical care provision? 
 
INTERVIEWER: How does running an independent retail pharmacy currently compare 
with running other retail businesses?  
SUBJECT:  Yes it is. Very much different. Sorry (customer interrupts) 
INTERVIEWER: We were comparing running a retail pharmacy to running any other 
business 
SUBJECT: No.1 you got to be aware of the drugs and the drug interactions 
INTERVIEWER:.The technical aspects 
SUBJECT: The technical aspects, the chemical aspects. For example if you go to Pick 
n Pay you don’t have to say, are you allergic to fish, are you allergic to chicken 
INTERVIEWER: I’ve got that 
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SUBJECT: Or even clothes, it’s the chemical and technical aspects of running of a 
pharmacy. And the ability to explain to the various customers the various conditions 
and how one would alleviate these certain conditions by means of taking certain drugs 
and the c/I of the 
INTERVIEWER: In that technical space it would be different. On a business outlook? 
Would you leave a pharmacy to run a KFC franchise 
SUBJECT: It’s a different thing, there’s registration there’s all this crap you got to do. 
If you opened a clothing shop or a fast food shop, u don’t need to get licences and 
there’s got to be so many sq meters and all this sh..t! You just open and get a trading 
licence. There’s a difference 
INTERVIEWER: And you continue to trade. But wholistically, as with other 
independently owned businesses competing in the same space as macro entities 
SUBJECT: I would say, I give community pharmacy 10 years in which they close down 
INTERVIEWER: You think so? That’s grim! 
SUBJECT: No, no I will give them 10 years. No1, the challenge of community 
pharmacy in regards to Dischem, and Pick n Pay and all that sh…t. There’s a big 
difference. As you can see I had a lot of fancy goods and cosmetics which has been 
thrown out. No.1 Dischem, their brand lines, as well their shampoos, their vitamins are 
exceptionally much cheaper than the individual pharmacies and you as a pharmacist 
you wouldn’t buy Berocca from me if you can get Berocca if R30 or R40 cheaper at a 
Dischem 
INTERVIEWER: Yeah 
SUBJECT: I would say, I give community pharmacies 10 years before they close 
down. That’s the one aspect.  
INTERVIEWER: For sure 
SUBJECT: I mean when I qualified 1965, there wasn’t this sh….t You dispensed, your 
dispensing fee and that’s it. And there was an ethical law which stated, what was the 
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law saying. It said, you cannot say to a customer go this pharmacy its cheaper than 
that pharmacy. and the medical aids could not direct . 
INTERVIEWER: Oh, is it? Where they go 
SUBJECT: Could not direct a pharmacy and say listen Glendower doesn’t do 
fedhealth go to medicare that’s the difference 
SUBJECT:  
INTERVIEWER: You see it then speaks to the changes in the trends in the last 5 years 
SUBJECT: There’s a big change! Let me tell you something your profit margin that 
time was 50% you could make a good living, your profit margin now is about 12 – 14%. 
How could you survive on that on that percentage. You see these idiots that don’t 
understand the efficacy of running a business. They don’t understand. They say you 
work on this margin or that margin. 
I wanna ask you a question, do you know how many pharmacists and I’m sure you 
well aware of this: You have a good customer, very good customer and they come 
and say listen give an antibiotic for my son ,give me some amoxyl®, give me some 
moxypen®. What do you say, f..k off. They gonna go down there 
INTERVIEWER: No, and they get it! That’s true 
SUBJECT: You say sure come in and they get it. This f…ken Pharmacy Council u 
cant even give a pill without a f…ken prescription. I mean u cant give injections have 
you heard of it a pharmacist cannot give injections of vit bco. They are mad! They have 
f…d up the pharmacy completely. 
INTERVIEWER: Whom? You mean the pharmacy council? 
SUBJECT: They are not for the pharmacists! 
INTERVIEWER: No, They do say their mandate is for the public and not for us the 
pharmacists even though we pay the fees. 
Customer interrupts 
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SUBJECT: Can I just help the lady there? 
INTERVIEWER: Yes sure 
SUBJECT: They say age before beauty! 
Laughter 
INTERVIEWER: We were discussing the trends in the last 5 years. We spoke about 
the medical aids are forcing people to go to certain pharmacists, the pharmacy council 
SUBJECT: That’s wrong! They should not do that. They should say right equal 
providers. You can go to Dischem, you can go this one but the price is the same. And 
that’s what hit a lot of pharmacies. I don’t know if you remember when this bl…dy 
b…tch, this alcoholic, the minister OF HEALTH, what’s her name? That bloody drunk 
addict. Nkambala? The one they did a transplant, and started drinking again, the one 
did their 
INTERVIEWER: Ehm  
SUBJECT: But I’m saying, She started this, why didn’t she go for the dentists why 
didn’t she go for the doctors. Do you know how many pharmacies closed their doors 
when she started this your mark up must be this or that? 490 PHARMACIES 
INTERVIEWER: Do you think the bigger culprit is the medical aids, pharmacy council 
or doh? 
SUBJECT: The whole 3 together.no 1 the medical councils said go this person and to 
that person, the doh underlines the medical councils so they feel the efficacy and the 
probability of the poorer class of whatever it is that they don’t have to outlay a levy or 
whatever,  is a better proposition. all 3 together, the pharmacy council as well, the 
whole lot 
INTERVIEWER: So there’s definite trends and changes of the last few years 
SUBJECT: There’s a lot of changes! i mean years ago, years ago, you could have 
gone if there was a problem. I will tell you what happens years ago. i was smoking 
right in the back, you know away from this, by the office 
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Customer interruption 
SUBJECT: The one guy gave 10, the other guy 15, the other guy gave 20, the other 
guy gave 25 and the other 30, you know what I mean. But we were forced to do this 
because this minister of health, she f…d everything 
INTERVIEWER: You mean they gave what do you mean they gave.. 
SUBJECT: Discounts 
INTERVIEWER: Oh you mean discounts 
SUBJECT: I mean when I qualified, it was one price. You could go from here to Durban 
to Cape Town and it was one dispensing price. And that was levelled, that was good. 
There wasn’t reduction in price, reduction. Alright we used to sell, we would give a 
10% discount whatever you want shampoos, conditioners all that sh…t. At the moment 
I don’t see a future for community pharmacies. This is my opinion. 
INTERVIEWER: I had hoped there would be some promise in pharmacists doing more 
pharmaceutical care stuff. That makes which makes you different from a an ordinary 
retail shop, that which makes you different from a herbal shop - The advice to the 
patient, the care in terms of professional care. Is that still an avenue pharmacists can 
pursue? 
SUBJECT: Very much so. If you go, let’s say you go Dischem theres Mr A one side , 
Mr B 
Customer interruption 
You see the reason they come to a community pharmacy, all the years. You speak to 
them, their kids were small, they growing up, they ask advice. A Dischem has got a 
Mr van Tonder there next day Mr van der Merwe following day Mrs Pampapoer 
following day this pharmacist. You can never correlate everyone together and get a 
relationship with somebody. 
INTERVIEWER: So the, the independent pharmacies are still bigger on 
pharmaceutical care, they provide pharmaceutical care 
 51 
SUBJECT: Very much so, very very much so 
INTERVIEWER: I hope and wonder how pharmacists can grow that p/care to make it 
viable. Because that’s what distinguishes you from a herbal shop. 
SUBJECT: I tell you what they can do, get hold of the m/aid and say listen let the 
customers go to whichever pharmacy they want. No levies to be charged throughout 
of South Africa. Not one price there and one price there, one price there ,it doesn’t 
work like that. 
INTERVIEWER: So those DSP’s, the arrangements with the medical aids are a 
problem. 
SUBJECT: Of course it is. 
INTERVIEWER: One pharmacist questioned whether the DSP’s are even legal. 
SUBJECT: No its not legal. I remember like I’m saying, now I remember one of the 
pharmacy laws was’ you will not taut for prescriptions. But now the medical aids are 
now indirectly touting for prescriptions. They are saying take your prescription and go 
this pharmacy. Go to Medirite, go to Pick n Pay, go to Dischem -we have a contract 
with Dischem. That is touting for prescriptions. That’s one of the ethical rules maybe 
they have done away with it now, I don’t know. You must check on that. 
INTERVIEWER: I must check on the act, the pharmacy act or the medicines and 
related substances act. 
SUBJECT: Like I said one of the main components is you shall not tout for 
prescriptions. You cannot say, a dr there… he cannot say dr Marais, listen don’t go to 
Rodney his prices are high go to Dischem you’ll get a better deal. You cannot do that. 
INTERVIEWER: Yes that’s wrong. The medical aids in essence have gained much 
power 
SUBJECT: Of course they have gained much power. I mean I have very good friends, 
I’m talking friends, they will not come here because they are good friends of mine. 
They say Ronnie why must I pay a levy of R140 when I can go to Medi rite and I don’t 
pay nothing. You would do the same if you and I were good friends, and you lived 
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around the corner and came for dinner and whatever it is. You understand im saying, 
you cant blame them. And that’s where the problem, there’s got to be a complete 
turnaround of pharmacy in regards the community in regards to the big DSP, there’s 
got to be a change. And they not prepared to give it to you. And that’s the problem. I 
mean these guys on the pharmacy council, they know nothing, what do they know, 
they know extremely fuckall. They should get a pharmacist who goes.. like , like who 
can .. can go around and say look what is going on in pharmacy.. this is wrong. 
INTERVIEWER: One who has owned because if u worked for someone its diff to when 
u have owned the entity. 
SUBJECTS: Let me tell you something, I have owned this place for 34 years, I told 
you. I have sold and I made a loss but I couldn’t handle it. Its not that. The cars break 
down, the accounts this this and I worked from. This, this, and I worked from 8 am in 
the morning till 11 pm at night, 7 / 11. Couldn’t do that anymore. Now I finish at 6pm, 
I go home have dinner with the family and whatever it is. 
INTERVIEWER: All the other stress belongs to somebody else. 
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APPENDIX V: FIFTH INTERVIEW  
Retail pharmacists’ perceptions of factors influencing the viability of practice 
and business in Johannesburg, Gauteng province 
Date: 22 June 2018 
Time: 15h45 
Introduction: As per the paperwork/letter handed to the subject 
The following were used as a guide to the interview: 
1. How would you compare running an independent retail pharmacy with running 
a different retail business? 
2. Has there been a change in retail pharmacy business trends in the last 5 -10 
years? 
3. What changes have you noted in pharmaceutical care provision? 
 
INTERVIEWER: How does running an independent retail pharmacy currently compare 
with running other retail businesses?  
SUBJECT:  Like a clothing shop 
INTERVIEWER: A clothing shop, a KFC or any other  
SUBJECT: In terms of the business side of it, its very much the same, you are still 
running a business and are looking at profits and you looking at the technical aspects. 
But when it comes to pharmacy we are not dealing with commodities, we are dealing 
with people who are really looking for assistance and that’s what makes it different to 
running another retail store. Like, its not like someone buying a t-shirt or a jersey where 
you just look at size and whether you like it whereas here we really have to start using 
our knowledge to be able to assist patients and to be able to make a difference. So I 
think its very much different in that terms, at the end of the day its still running a 
business. We still looking at the numbers, you still must make a profit, you still must 
pay the bills, you still have to pay rent so the technical things are still the same 
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INTERVIEWER:. You must still make a profit 
SUBJECT: But I think its more fulfilling because you actually helping people in a 
different way you meeting someone’s needs and I think that’s critical 
INTERVIEWER: That’s very true because now you look at its just the product they are 
buying, what more are they looking for 
SUBJECT: So we are adding value to a product. So if someone comes in with a script, 
they coming with a piece of paper with words on them which they don’t even know 
what they mean. And I think at least what I see in my own practice is that doctors don’t 
– they just script and they give to the patient “ go to the pharmacy they will give you” 
so they sometimes don’t even know what the doctor has given them.  
INTERVIEWER: Yes they don’t know most times 
SUBJECT: Either they are too scared to ask the doctor because they could be in a 
position where they are very stressed and they forget to ask and then we become the 
point where we become the conversation for the patient.  
INTERVIEWER: Yes, the person to talk to. 
SUBJECT: Exactly. We end giving up a lot of value over and above what we are trying 
to sell. And then we do add ons, so we say ok  – this will help you in a different way- 
we provide lifestyle modification advice and. You know there some things, simple 
things we know we should do but you need someone to tell you to do them, to reinforce 
what you already know. So, we do add value in that sense 
INTERVIEWER: And I think they do feel different to when they leave the doctor’s 
rooms its different to when they leave a pharmacy 
SUBJECT: Ya, that’s why I moved to a bigger store and  I wanted it to be airy and 
bright coz when people come, when they walk into your door, they usually stressed 
INTERVIEWER: Yes 
SUBJECT: You want them, when they walk out of door, you want them to feel a bit 
happier 
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INTERVIEWER: A bit calmer 
SUBJECT: It’s the environment that the different pharmacies create. You know when 
you walk in. Like when you have a happy picture instead of a grey sitting room, any 
doctor’s rooms is scary coz you always apprehensive 
INTERVIEWER: A clinic effect, the white collar/ jacket effect 
SUBJECT: The white jacket effect. So it makes a difference in the pharmacy, in 
independent pharmacy - coz we all have our own looks, we all have our own styles 
we take than on into our businesses. 
INTERVIEWER: You actually portray that in the way you run your business. 
SUBJECT: So, with every independent pharmacy. The Clicks’ all have the same style, 
the Dischems all have their own styles 
SUBJECT: Or have the franchise style. Now as independents pharmacists we are 
fortunate in that we can add our own little personality to it. We don’t have anon-
pharmacist telling us what to do. 
INTERVIEWER: I loved that. That one thing I loved, trying out what I would like to try. 
SUBJECT: That’s what for me Is fulfilling. This is me, the walls and things is designed 
by me. Its not someone telling you taking up too much space and I mean come pray 
at my temple sometimes (referring to a Hindu temple/altar in his office), where would 
you find that at a Clicks or a Dischem. 
INTERVIEWER: No you don’t. 
SUBJECT: Because that’s how independents run. 
INTERVIEWER: Also you know Ndumi, you know John etc. 
ISUBJECT: We phone them on their phones its quick quick, its different. 
INTERVIEWER: What changes in retail pharmacy business trends have you noticed 
in the last 5 -10 years? 
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SUBJECT: There’s a lot of change. Firstly the medical aids right. The medical aids is 
a big thing, there’s been huge changes in the medical aids part where they’ve changed 
their regulations wrt DSP’s. Five years ago I would service say 100 HIV patients and 
then the medical aid came up with the rule that they cant get it at an independent 
pharmacy, it has to be couriered to them or a corporate pharmacy. So that was huge 
for me because we lost all our patients we were taking care of because they would 
pay an additional 20 % out of their pocket. 
INTERVIEWER: They moved, most cant afford that 
SUBJECT: Most cant afford that. You really think that one pays such a high amount 
for their medical aid, you would expect them to cover that 
INTERVIEWER: To cover anything for your chronic condition 
SUBJECT:  Exactly. The thing is that, that has changed. The biggest thing is the way 
this DSP thing works. Its an unfair practice to independents, because we can provide 
the same service as corporates provide, probably even a better service. I think a way 
better service than the courier pharmacy who doesn’t even speak to the patient. 
INTERVIEWER This is what most pharmacists have told me. I spoke to a guy who has 
both Dischem and Clicks in the same centre. He asked a very interesting question that 
are these DSP’s even legal, if are they not a contravention of some law,  
SUBJECT: It is a contravention I think, you know they say they don’t want pervese 
incentives, this is a peverse incentive to a different party. 
INTERVIEWER: True, its indirect tauting 
SUBJECT: I have patients that get their meds couriered to them, so the box goes 
straight to the home or to the workplace. Sometimes they come in here, they open the 
box in front of me and ask “Deevesh what is this, it looks different to me, I’m too scared 
to take it” coz sometimes they are not even told what they are getting or they are told 
but cannot visualise coz they don’t have that one on one with a pharmacist. 
INTERVIEWER: If they are told, they are not sometimes. 
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SUBJECT: For me it’s a saddening part because we lost those patients so you loose 
a part of your business right. As a pharmacist you loose their care coz sometimes they 
come with an acute script and you forget that they are on another script and you like 
‘Oh no, now what” and some of them don’t even tell you sometimes. Because they 
getting theirs couriered by a different pharmacy. 
INTERVIEWER: They are on warfarin 
SUBJECT: So we give them a brufen® because that’s best for their muscle pain 
INTERVIEWER: So they are getting treated at different points, why should we do that 
to patients. For me that’s very unfair. 
SUBJECT:  
INTERVIEWER: I think it also infringes, this is my personal view, on a person’s right 
to choose where they get service provision. 
SUBJECT: Exactly 
INTERVIEWER: That is the biggest thing, changes in the medical aids and then the 
uprise of all these corporate pharmacies in every nook and corner. I mean in town we 
used to be – independent pharmacies used to rum the cbd, Braamfontein and we used 
to add our value. If you look at it now there’s a Dischem and there’s Clicks coming up 
soon. So the corporates are just invading all space, every nook and crook they wanna 
get into. But that’s business, and business is not always nice. Their core business is 
not pharmacy that’s where I have an issue.  
SUBJECT: Yes 
SUBJECT: They are business people selling 2 for 1 deals of cosmetics, which is great. 
I go shopping at Dischem. 
INTERVIEWER: I do too 
SUBJECT: Because I get cheap stuff. But I don’t go there to get help when im sick. I 
rather go to a pharmacy or a doctor you know coz that’s their core speciality. 
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INTERVIEWER: And that’s why I call shopping at the corporates a wholesale 
experience and going at an independent pharmacy, a boutique experience. 
SUBJECT: Exactly. So that’s a big trend over the last few years. I mean Dischem only 
came last year and I heard there’s a Clicks coming up and today i heard that a Pick n 
Pay is opening around the corner. 
INTERVIEWER: I believe their markets are different, I really truly believe your market 
is different to the Dischem, to the Clicks client. It seems intimidating initially but when 
you really think about it you will see they have different markets 
SUBJECT: Its how you sell yourself to your client 
INTERVIEWER: Yes, to your prospective client 
SUBJECT: Because look, my front shop is small. I don’t keep Pantene® and 
Organics®  its not my core, its not where I want to focus on but what I wanna focus on 
– you can see my dispensary is bigger than my front shop, almost! 
INTERVIEWER: Its sizeable even compared to some Clicks dispensaries 
SUBJECT: Exactly, because this is where my core business is providing medication. 
You know there is so many changes. And then with the corporates coming in, they 
competing with price 
INTERVIEWER: Economies of scale come into play 
SUBJECT: Economies of scale come into play, that’s a big thing for independent 
pharmacies. And we don’t have the support corporates have. They have buying power, 
their own wholesalers. 
INTERVIEWER: That’s already cutting down on logistics fees which gives them at 
least 10 % leverage. So those are big things affecting independents, I think 
SUBJECT: Clinics have become big now, that’s trending now in most pharmacies no 
where most pharmacies are keeping clinics. That’s the direction that we will find 
ourselves in eventually 
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INTERVIEWER: Yes, That’s leading me to the next one, is that now how we should 
be considering pharmaceutical care as being the centre of retail or community 
pharmacy practice. What changes have you noted in pharmaceutical care. You just 
said to me that there is more clinics opening up which means there is bigger 
recognition for pharmaceutical care and more primary healthcare versus commodity 
trading 
SUBJECT: I think eventually there’s going to need to be a balance between the two 
because commodity trading will always be there, will be the at the core part of the 
pharmacy but a big add on will have to be a focus on primary healthcare. So, screening 
will be a big thing, screening will be important and also being able to assist in some of 
the key standard issues that everybody is exposed to. The common things like maybe 
STD’s, contraception EHHMM 
INTERVIEWER: Those are still issues, people think they are not. They still issues 
SUBJECT: They are issues, exactly. i think sometimes we can add value there. 
People’s lives have become too busy. 
INTERVIEWER: And also the trend in the disease profile of the country is pointing 
towards lifestyle diseases and those need education, healthcare interventions and 
participation a lot more than wha was infectious disease where we gave you a course 
of antibiotics and we new that would sort you out. But now we have your gouts, 
diabetes 
SUBJECTS: There’s too many multiple things happening together and that’s a big 
issue. Clinics, I think is what’s going to change the face of pharmacy at some point or 
its going to be an important add on to a pharmacy. 
INTERVIEWER: It’s going to grow it bigger. But how pharmacists use that is key. For 
instance if you have clinic runs and you have outsourced it and want nothing to do 
with it. But it doesn’t talk to each other, its got to be incorporated somehow. 
SUBJECT: It’s got to be incorporated. For me, I’m still thinking about the clinic, I have 
3 ways I’m thinking about how to do it. 
INTERVIEWER: So the clinics, more pharmaceutical care is our hope for the future 
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SUBJECT: More holistic care. The biggest mistake was allowing non-pharmacists to 
own pharmacies. Every tier has contributed, from government to Pharmacy Council. 
INTERVIEWER: They all contributed to the demise, would you call it a demise? 
SUBJECT: I wouldn’t call it a demise, it’s a change. 
INTERVIEWER: Thank you so much for your time and input. Its truly appreciated. 
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APPENDIX VI: LIST OF CHRONIC CONDITIONS ON PRESCRIBED MINIMUM 
BENEFITS 
i. Addison’s disease 
ii. Asthma 
iii. Bronchiectasis 
iv. Cardiac failure 
v. Cardiomyopathy 
vi. Chronic Obstructive Pulmonary Disorder 
vii. Chronic renal disease 
viii. Coronary artery disease 
ix. Crohn’s disease 
x. Diabetes Insipidus 
xi. Diabetes mellitus types 1 & 2 
xii. Dysrhythmias 
xiii. Epilepsy 
xiv. Glaucoma 
xv. Haemophilia 
xvi. Hyperlipidaemia 
xvii. Hypertension 
xviii. Hypothyroidism 
xix. Multiple sclerosis 
xx. Parkinson’s disease 
xxi. Rheumatoid arthritis 
xxii. Schizophrenia 
xxiii. Systemic lupus erythematosus 
xxiv. Ulcerative colitis 
xxv. Bipolar Mood Disorder 
xxvi. HIV/AIDS 
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APPENDIX VII: LETTER FROM THE LANGUAGE PRACTITIONER 
 
